Drug Shortage Report for WIXELA INHUB

Last updated on 2025-01-28 History
Report ID 248189
Drug Identification Number 02495597
Brand name WIXELA INHUB
Common or Proper name SALMETEROL FLUTICASONE PROPIONATE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) SALMETEROL FLUTICASONE PROPIONATE
Strength(s) 50MCG 100MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size Inhaler
ATC code R03AK
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-01-21
Actual start date
Estimated end date 2025-01-23
Actual end date 2025-01-24
Shortage status Resolved
Updated date 2025-01-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-01-28 French Compare
v4 2025-01-28 English Compare
v3 2025-01-22 English Compare
v2 2025-01-21 French Compare
v1 2025-01-21 English Compare

Showing 1 to 5 of 5